中国动脉粥样硬化网 >> 网站地图 >> 第93页:
http://www.sinoas.com/SiteMap/Article002.htm
  • 胺碘酮影响美托洛尔的代谢Amiodarone Affects Metoprolol Metabolism
  • 冠心病患者戒烟后可很快看到益处Benefits Quickly Seen After Smoking Cessation in Coronary Heart Disease Patients
  • ICDs改善了非缺血性心肌病的生存ICDs Improve Nonischemic Cardiomyopathy Survival
  • 急性心梗后应用ICD未降低总死亡率ICD Use After Acute MI Does Not Reduce Overall Mortality
  • 指尖测试可识别早期冠心病患者Fingertip Test May Identify Patients With Early Coronary Artery Disease
  • 患者自服氟卡尼或普罗帕酮治疗再发性房颤安全、有效Self-Administered Flecainide or Propafenone Safe, Effective for Recurrent Atrial Fibrillation
  • 组织ACE亲和力与心梗（MI）危险无关Tissue ACE Affinity Not Tied to MI Risk
  • 阿托伐他汀可抑制家族性高胆固醇血症患者的动脉粥样硬化Atorvastatin Arrests Atherosclerosis in FH
  • 抗炎蛋白水平增高可降低心梗危险High Levels of Anti-Inflammatory Protein Cut MI Risk
  • 女性的PCI死亡危险与男性相似PCI Death Risks Similar between Genders
  • 血管对血管紧张素II的反应下降可预测CABG后的心血管事件Diminished Vascular Response to Ang II Predicts CV Events After CABG
  • 冠心病患者戒烟后可很快看到益处Benefits Quickly Seen After Smoking Cessation in Coronary Heart Disease Patients
  • 胺碘酮影响美托洛尔的代谢Amiodarone Affects Metoprolol Metabolism
  • 卡维地洛没有使血糖控制恶化，同时可改善代谢综合征Carvedilol Does Not Appear to Worsen Glycemic Control and May Improve Metabolic Syndrome
  • 大多数冠心病患者的糖代谢异常Glucose Metabolism Abnormal in Most CAD Patients
  • 在严重慢性心力衰竭患者中短期间断静脉应用多巴酚丁胺对血管内皮功能的影响Impact of short-term intermittent intravenous dobutamine therapy on endothelial function in patients with severe chronic heart failure
  • 应用雷帕霉素涂层支架治疗分支冠脉病变：随机比较简化治疗方案和复杂治疗方案Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: A randomized comparison of a simple versus complex strategy
  • 冠状动脉搭桥的一年通畅率PRAGUE-4试验中随机比较非体外循环和体外循环手术的血管造影结果One-Year Coronary Bypass Graft PatencyA Randomized Comparison Between Off-Pump and On-Pump Surgery Angiographic Results of the PRAGUE-4 Trial
  • 微波技术可稳定不规则心跳Microwave Technology Steadies Irregular Heartbeat
  • 他汀在心梗期间有保护作用Statins Appear to Be Protective During MI
  • 急性心梗血管成形术后应用阿司匹林可显著改善早期和晚期生存Aspirin After Angioplasty for Acute MI Significantly Improves Early and Late Survival
  • 女性的卒中危险与其家族史密切相关Womens Stroke Risk Tied to Family History
  • 新的低分子量肝素减少心梗后死亡和再梗塞New Low Molecular Weight Heparin Reduces Mortality, Reinfarction After MI
  • 计算机误诊了1/3的房颤（AF）病例Computers Misdiagnose a Third of AF
  • 补充维生素E可增加死亡率Vitamin E Supplements May Increase Mortality
  • 非ST段抬高急性冠脉综合征的长期死亡危险高Long-Term Mortality Risk High in Non-ST Elevation Acute Coronary Syndrome
  • CRP进一步确认为CHD的预测指标CRP further established as CHD marker
  • 二尖瓣脱垂与腹腔动脉狭窄密切相关Mitral Valve Prolapse Tied to Celiac Artery Stenosis
  • 新检测到的血糖异常可预示心梗后的心脏事件Newly Detected Glucose Abnormalities Predict Future Cardiac Events After MI
  • ICDs改善了非缺血性心肌病的生存ICDs improve nonischemic cardiomyopathy survival
  • 停用NSAID治疗后数周心梗的危险增加Risk of MI Increased for Several Weeks After Stopping NSAID Therapy
  • 急性心梗后应用ICD未降低总死亡率ICD Use After Acute MI Does Not Reduce Overall Mortality
  • 与罗非昔布不同的是，塞来昔布与心梗危险增加不相关Unlike Rofecoxib, Celecoxib Not Linked to Increased Risk of MI
  • 指尖测试可识别早期冠心病患者Fingertip Test May Identify Patients With Early Coronary Artery Disease
  • 冠心病常常伴有代谢综合征Coronary Disease Often Accompanies Metabolic Syndrome
  • AMI死亡率的性别差异并非只归因于AMI严重性的不同AMI Severity Does Not Explain Gender Differences
  • 戒烟可使心脏病患者获益很多CHD benefits abound on quitting smoking
  • 急性冠脉综合征患者中肾功能不全和肌钙蛋白I阳性之间的临床联系Clinical Association between Renal Insufficiency and Positive Troponin I in Patients with Acute Coronary Syndrome.
  • 曲美他嗪改善老年冠心病患者的左心室功能和生活质量Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease
  • 冠状动脉微栓塞中无灌注心肌的数量和左室功能表面积之间的关系Relation of Nonperfused Myocardial Volume and Surface Area to Left Ventricular Performance in Coronary Microembolization.
  • 过去十年美国的慢性肾衰发病增加了一倍Prevalence of Chronic Kidney Failure in US Doubled in Last Decade
  • 轻度肾脏疾病预测心肌梗死后的心血管并发症Mild Renal Disease Predicts Cardiovascular Complications After Myocardial Infarction
  • 肾小球滤过率降低与心梗危险增加相关Low Glomerular Filtration Rate Linked to High MI Risk
  • 运动试验可预测男性发生冠心病Exercise test predicts CHD in men
  • 他汀使进行经皮冠脉介入术（PCI）后的所有心绞痛病人获益Statin Benefits All Angina Patients After PCI
  • 急性冠脉综合症（ACS）后卒中的发生率虽低，但后果严重Stroke incidence after ACS low but devastating
  • 急性心梗患者溶栓失败后植入支架效果最好Stenting best after failed thrombolysis in AMI patients
  • 麻黄素增加了致死性心律失常的危险Ephedrine Increases Risk of Lethal Cardiac Arrhythmias
  • 自己服用氟卡尼或普罗帕酮治疗再发性房颤安全、有效Self-Administered Flecainide or Propafenone Safe, Effective for Recurrent Atrial Fibrillation
  • 分离方法可降低CABG中的微栓塞危险Separation Method Could Lower Risk of Microemboli in CABG
  • 组织ACE亲和力与心梗（MI）危险无关Tissue ACE Affinity Not Tied to MI Risk
  • 微波技术可稳定不规则心跳Microwave Technology Steadies Irregular Heartbeat
  • 大多数冠心病患者的糖代谢异常Glucose metabolism abnormal in most CAD patients
  • 急性心梗血管成形术后应用阿司匹林可显著改善早期和晚期生存Aspirin After Angioplasty for Acute MI Significantly Improves Early and Late Survival
  • [AHA 2004] 骨髓细胞对STEMI提供持续的益处Bone marrow cells offer continued STEMI benefits
  • 肾小球滤过率降低与心梗危险增加相关Low Glomerular Filtration Rate Linked to High MI Risk
  • [AHA2004] 补充维生素E可增加死亡率Vitamin E supplements may increase mortality
  • [AHA2004] 新的低分子量肝素减少心梗后死亡和再梗塞New Low Molecular Weight Heparin Reduces Mortality, Reinfarction After MI
  • [AHA2004] 卡维地洛没有损害血糖控制，同时可改善代谢综合症Carvedilol Does Not Appear to Worsen Glycemic Control and May Improve Metabolic Syndrome
  • 一些ACS患者早期心导管术应用不足Early catheterization underused in some ACS patients
  • 他汀在心梗期间有保护作用Statins Appear to Be Protective During MI
  • 计算机误诊了1/3的房颤（AF）病例Computers misdiagnose a third of AF
  • 急性心梗患者溶栓失败后植入支架效果最好Stenting best after failed thrombolysis in AMI patients
  • 肾小球滤过率降低与心梗危险增加相关Low Glomerular Filtration Rate Linked to High MI Risk
  • 针对高血压和血脂异常的二合一药丸Two-for-One Pill Targets Both Hypertension and Dyslipidemia
  • Polypill-即将面世The Polypill-Coming Soon
  • 主动脉粥样硬化：危险因子、危险标记物或无关的旁观者？一项人群中经食管超声心动图的前瞻性研究Atherosclerosis of the aorta: risk factor, risk marker, or innocent bystander? A prospective population-based transesophageal echocardiography study.
  • 接受心肌灌注单光子发射计算机断层摄影检查的患者发生房颤的前瞻性预测Prognostic implications of atrial fibrillation in patients undergoing myocardial perfusion single-photon emission computed tomography.
  • CABG或者支架置入后的3年死亡和主要事件发生率相似Mortality and Major Events Rate Similar 3 Years After CABG or Stent
  • 大脑微出血不是心血管危险因子Cerebral Microbleeds Not Linked to Cardiovascular Risk Factors
  • 使用药物涂层支架获益有限Benefits of Drug-Coated Stents Limited
  • 过去十年美国的慢性肾衰发病增加了一倍Prevalence of Chronic Kidney Failure in US Doubled in Last Decade
  • 他汀使进行经皮冠脉介入术（PCI）后的所有心绞痛病人获益Statin Benefits All Angina Patients After PCI
  • 运动试验可预测男性发生冠心病Exercise test predicts CHD in men
  • 心房利钠尿肽对急性缺血性肾衰竭有益Atrial Natriuretic Peptide Helpful for Acute Ischemic Renal Failure
  • ACTION：研究长效控释硝苯地平对冠心病预后的试验ACTION: A Coronary Disease Trial Investigating Outcome With Nifedipine Gastrointestinal Therapeutic System (GITS)
  • 抗血小板制剂应用专家共识报告ESC关于动脉粥样硬化性心血管疾病患者应用抗血小板制剂专题工作组
  • 急性冠脉综合征出院后坚持循证治疗：一项正在进行的前瞻性观察研究Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
  • 循证疗法是心肌梗死治疗的长期趋势和决定因素Evidence-based therapies for myocardial infarction: secular trends and determinants of practice in the community.
  • 急性心梗后PCI治疗的安全和有效间隔天数PCI Safe and Effective Days After Acute Myocardial Infarction
  • 在心梗患者中BNP水平与死亡率密切相关BNP Levels at Presentation Tied to Mortality in MI Patients
  • 阿托伐他汀改善冠心病病人的肾功能Atorvastatin Improves Renal Function in Patients With Coronary Heart Disease
  • 阿托伐他汀预防冠心病的成本效益分析——ASCOT研究的一项分析Cost-effectiveness of atorvastatin for the prevention of coronary disease. An analysis of the ASCOT study
  • 反复血管成形术使医疗保险方案的费用增加了上百万Repeat Angioplasty Adds Millions to Medicare Costs
  • 冠状动脉钙是一个独立的CHD事件预测因子Coronary Artery Calcium an Independent Predictor of CHD Events
  • 维生素B可增加冠状动脉支架置入后再狭窄的风险B Vitamins May Increase Risk of Restenosis After Coronary Stenting
  • 在CAD检查中无创性PET/CT的准确性与冠状动脉血管造影术相同Noninvasive PET/CT as Accurate as Coronary Angiogram in Detecting CAD
  • 对冠心病患者来说冠脉手术比支架术昂贵Coronary Surgery More Expensive Than Stenting for Coronary Artery Disease
  • 评价心绞痛的新指南New Guidelines for Evaluation of Angina
  • REVERSAL研究：80mg阿托伐他汀可阻止动脉粥样硬化，而40mg普伐他汀不能


    • 分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
    26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50
    51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75
    76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 [93] 94 95 96 97 98 99 100
    101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125
    126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150
    151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175
    176 177 178 179 180 181 182